Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2369800Generated: October 30, 2026

epsilon-tert-Butyloxycarbonyl-lysine → HCID 87554045, compound

https://huagongshe.com/reaction/2369800

Reaction equation

Participants

RoleNameHCIDCharge
Reactantepsilon-tert-Butyloxycarbonyl-lysineHCID 2733284—
Reactant2-(2,5-Dioxopyrrolidin-1-yl)-1,1,3,3-tetramethylisouronium tetrafluoroborateHCID 9857522—
Reactant16-(Tert-butoxy)-16-oxohexadecanoic acidHCID 57817723—
SolventDimethylformamideHCID 6228—
ProductHCID 87554045HCID 87554045—

Reaction Steps

Hexadecanedioic acid mono-tert-butyl ester can be activated with TSTU in similar fashion to the method described in Example 1, Step 6. The product can be reacted with Boc-Lys-OH in DMF at RT for 16 h. After concentrating under vacuum, AcOEt can be added the residue and the mixture can be washed with 0.2 N HCl. The organic phase is then dried over MgSO4 and concentrated under vacuum to yield the crude product, 15-((S)-5-tert-Butoxycarbonylamino-5-carboxypentylcarbamoyl)pentadecanoic acid tert-butyl ester. This can either be used without further purification or purified by flash chromatography. This compound can be activated with TSTU in similar fashion to the method described in Example 1, Step 6 to yield 15-[(S)-5-tert-butoxycarbonylamino-5-(2,5-dioxopyrrolidin-1-yloxycarbonyl) pentylcarbamoyl]pentadecanoic acid tert-butyl ester, and this compound can be coupled to insulin and deprotected to yield the title compound as described in Example 1, Step 7 using prepatative HPLC to isolate the product.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08710000B2
Source datasetuspto-grants-2014_04
ORD IDord-561880c8f4c34575ada51a40348d4d41
Source noteuspto-grants-2014_04